|
⚲
|
| Keyboard |
| Beardsley Robert A
✚
|
|
|---|---|
| CIK # | 0001310845 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001310845] | |
| 4 | [0001310845] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Beardsley Robert A | |
| Arbutus Biopharma Corp | |
| Galera Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2025-03-18 | Grant | 157,600 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2023-02-25 | Grant | 135,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option · derivative
|
2022-11-21 | Option exercise | 10,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2022-11-21 | Option exercise | 10,000 | $1.07 | 10,700 |
|
Galera Therapeutics Inc GRTX
Stock Option · derivative
|
2022-09-12 | Option exercise | 10,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2022-09-12 | Option exercise | 10,000 | $1.07 | 10,700 |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2022-02-28 | Grant | 75,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option · derivative
|
2021-12-17 | Option exercise | 20,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2021-12-17 | Option exercise | 20,000 | $1.07 | 21,400 |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2021-01-26 | Grant | 75,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2020-01-31 | Grant | 74,435 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Common Stock
|
2019-11-12 | Conversion | 15,361 | ||
|
Galera Therapeutics Inc GRTX
Series C Preferred Stock · derivative
|
2019-11-12 | Conversion | 6,774 | ||
|
Galera Therapeutics Inc GRTX
Series B Preferred Stock · derivative
|
2019-11-12 | Conversion | 2,000 | ||
|
Galera Therapeutics Inc GRTX
Series A Preferred Stock · derivative
|
2019-11-12 | Conversion | 68,907 |